132 related articles for article (PubMed ID: 12100210)
1. Pneumocystis carinii pneumonia in a patient on immunosuppressive drugs for pyoderma gangrenosum.
McGarry H; McLelland J
Br J Dermatol; 2002 Jul; 147(1):192-3. PubMed ID: 12100210
[No Abstract] [Full Text] [Related]
2. Pneumocystis carinii pneumonia in a patient with pyoderma gangrenosum treated with cyclosporin.
De Silva BD; Buxton PK
Br J Dermatol; 2000 Sep; 143(3):683-4. PubMed ID: 10971375
[No Abstract] [Full Text] [Related]
3. Two cases of fatal Pneumocystis jirovecii pneumonia as a complication of tacrolimus therapy in ulcerative colitis--a need for prophylaxis.
Escher M; Stange EF; Herrlinger KR
J Crohns Colitis; 2010 Nov; 4(5):606-9. PubMed ID: 21122569
[TBL] [Abstract][Full Text] [Related]
4. [Pneumocystis carinii and aspergillus pneumonia in immunosuppression in rapidly progressing glomerulonephritis of the anti-glomerular basement membrane type].
Späth M; Schollmeyer P
Med Klin (Munich); 1996 Sep; 91(9):603-6. PubMed ID: 8984320
[No Abstract] [Full Text] [Related]
5. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
6. [Pneumocystis carinii pneumonia: a life threatening complication after kidney transplantation].
Chlebowski H; Westhoff A; Bach D; Grabensee B
Med Klin (Munich); 1992 Oct; 87 Suppl 1():49-52. PubMed ID: 1461228
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy.
Glück T; Geerdes-Fenge HF; Straub RH; Raffenberg M; Lang B; Lode H; Schölmerich J
Infection; 2000; 28(4):227-30. PubMed ID: 10961529
[TBL] [Abstract][Full Text] [Related]
8. [Pneumocystis jiroveci pneumonia in immunocompromised patients without AIDS -- a case series].
Blum T; Roth A; Mauch H; Erbes R; Lode H
Dtsch Med Wochenschr; 2006 Jul; 131(27):1515-20. PubMed ID: 16817100
[TBL] [Abstract][Full Text] [Related]
9. [Pneumocystis carinii infection in a patients with LED].
Saha H; Lumio J; Soppi E; Pietilä K; Pasternack A
Duodecim; 1992; 108(2):173-6. PubMed ID: 1365999
[No Abstract] [Full Text] [Related]
10. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.
Mecoli CA; Saylor D; Gelber AC; Christopher-Stine L
Clin Exp Rheumatol; 2017; 35(4):671-673. PubMed ID: 28134084
[TBL] [Abstract][Full Text] [Related]
11. A case of new-onset rheumatoid vasculitis becoming evident in the course of treatment for Pneumocystis jirovecii pneumonia.
Ikuma D; Yokota K; Sato K; Mimura T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):78-82. PubMed ID: 28539558
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive Treatment and Its Effect on the Occurrence of Pneumocystis jiroveci, Mycoplasma pneumoniae, Chlamydophila pnemoniae, and Legionella pneumophila Infections/Colonizations Among Lung Transplant Recipients.
Wojarski J; Ochman M; Latos M; Biniszkiewicz P; Karolak W; Woźniak-Grygiel E; Maruszewski M; Urlik M; Mędrala W; Kułaczkowska Z; Pyrc K; Żegleń S
Transplant Proc; 2018 Sep; 50(7):2053-2058. PubMed ID: 30177108
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation.
Brakemeier S; Pfau A; Zukunft B; Budde K; Nickel P
Pharmacol Res; 2018 Aug; 134():61-67. PubMed ID: 29890253
[TBL] [Abstract][Full Text] [Related]
14. Pneumocystis carinii pneumonia complicating methotrexate treatment of primary sclerosing cholangitis.
Duerksen DR; Blondel-Hill E; Bailey RJ
Am J Gastroenterol; 1995 Oct; 90(10):1886-7. PubMed ID: 7572917
[TBL] [Abstract][Full Text] [Related]
15. Pneumocystis jirovecii pneumonia 13 years post renal transplant following a recurrent cytomegalovirus infection.
Muhammad Iqbal AH; Lim SK; Ng KP; Tan LP; Chong YB; Keng TC
Transpl Infect Dis; 2012 Aug; 14(4):E23-6. PubMed ID: 22551151
[TBL] [Abstract][Full Text] [Related]
16. Late onset opportunistic infections in a renal allograft recipient: a case report.
Morosi S; De Socio GV; Fiorio M; Stagni G
Infez Med; 2004 Jun; 12(2):136-8. PubMed ID: 15316301
[TBL] [Abstract][Full Text] [Related]
17. Question 1: Co-trimoxazole dosing dilemma: what is the right dose?
Boast A; Osowicki J; Cole T; Curtis N; Gwee A
Arch Dis Child; 2015 Nov; 100(11):1089-93. PubMed ID: 26408788
[No Abstract] [Full Text] [Related]
18. Pyoderma gangrenosum and necrotizing fasciitis-like opportunistic invasive cutaneous fungal infection.
Aytekin S; Güder H; Göktay F; Yaşar Ş; Aker F; Aksaray S
Int J Dermatol; 2016 Oct; 55(10):e563-5. PubMed ID: 27126743
[No Abstract] [Full Text] [Related]
19. Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis.
Gonzalez Santiago TM; Wetter DA; Kalaaji AN; Limper AH; Lehman JS
Int J Dermatol; 2016 Aug; 55(8):823-30. PubMed ID: 27009930
[TBL] [Abstract][Full Text] [Related]
20. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.
Cooley L; Dendle C; Wolf J; Teh BW; Chen SC; Boutlis C; Thursky KA
Intern Med J; 2014 Dec; 44(12b):1350-63. PubMed ID: 25482745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
